Technical Perspectives on Application Software Stocks — 2U, Allscripts Healthcare Solutions, Alteryx, and ANSYS

April 23, 2018

Responsive image

NEW YORK, April 23, 2018 /PRNewswire/ — strives to bring the best free research to the investment community.  Today we are offering reports on TWOU, MDRX, AYX, and ANSS which can be accessed for free by signing up to Ahead of today’s trading session, navigates the global Application Software space, which is a consolidated industry consisting of ERP, CRM, SCM, and business intelligence and analytics. Lined up for evaluation this morning are the following stocks: 2U Inc. (NASDAQ: TWOU), Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX), Alteryx Inc. (NYSE: AYX), and ANSYS Inc. (NASDAQ: ANSS). All you have to do is sign up today for this free limited time offer by clicking the link below.


Lanham, Maryland headquartered 2U Inc.’s stock finished last Friday’s session 1.51% lower at $84.22. A total volume of 351,345 shares was traded. The Company’s shares have advanced 16.36% over the previous three months and 92.94% over the past year. The stock is trading above its 50-day and 200-day moving averages by 2.03% and 30.28%, respectively. Additionally, shares of 2U, which operates as an education technology company in the US, Hong Kong, South Africa, and the UK, have a Relative Strength Index (RSI) of 51.36.  

On March 27th, 2018, research firm Goldman initiated a ‘Neutral’ rating on the Company’s stock, with a target price of $92 per share.

On April 13th, 2018, 2U announced that it will report its Q1 financial results on May 03rd, 2018. Christopher “Chip” Paucek, CEO and Co-founder, and Cathy Graham, CFO, will hold an audio webcast and conference call at 5:00 p.m. ET that same day to discuss the results. The live webcast may be accessed on the Company’s investor website. Get the full research report on TWOU for free by clicking below at:

Allscripts Healthcare Solutions

On Friday, shares in Chicago, Illinois headquartered Allscripts Healthcare Solutions Inc. ended the session 0.48% lower at $12.32. The stock recorded a trading volume of 910,579 shares. The Company’s shares have gained 3.62% over the past year. The stock is trading 6.33% below its 50-day moving average. Moreover, shares of the Company, which provides information technology solutions and services to healthcare organizations in the US, Canada, and internationally, have an RSI of 45.75.  

On April 02nd, 2018, Allscripts Healthcare Solutions (MDRX) closed the previously announced sale of its OneContent business to Hyland Software, Inc., a leading provider of content services solutions to the Healthcare industry and beyond. MDRX acquired the OneContent business in late 2017 through the acquisition of McKesson’s EIS portfolio. Access the free research report on MDRX now by signing up at:


Irvine, California headquartered Alteryx Inc.’s shares dropped 4.10%, closing the session at $35.98 with a total trading volume of 384,425 shares. The stock has gained 27.27% over the previous three months and 132.13% over the past year. The stock is trading 6.26% and 37.89% above their 50-day and 200-day moving averages, respectively. Additionally, shares of Alteryx, which operates a self-service data analytics software platform that enables organizations to enhance business outcomes and the productivity of their business analysts, have an RSI of 55.66.  

On April 10th, 2018, research firm Needham initiated a ‘Buy’ rating on the Company’s stock, with a target price of $39 per share.

On April 10th, 2018, Alteryx announced that it will report its Q1 2018 financial results after the US financial markets close on May 09th, 2018. The Company will host a conference call at 5:00 p.m. ET that same day to discuss its financial results and guidance. A live webcast of this conference call will be available under the “Investors” page of the Company’s website. Are you already registered with Wall St. Equities? Do so now for free, and get the report on AYX at:


Last Friday at the close, shares in Canonsburg, Pennsylvania headquartered ANSYS Inc. recorded a trading volume of 887,149 shares, which was above their three months average volume of 496,960 shares. The stock ended the session 1.03% lower at $163.78. The Company’s shares have advanced 1.39% over the previous three months and 51.63% over the past year. The stock is trading above its 50-day and 200-day moving averages by 1.83% and 14.19%, respectively. Furthermore, shares of ANSYS have an RSI of 55.33.  

On April 17th, 2018, ANSYS announced that it expects to release its Q1 2018 earnings on May 02nd, 2018, after market close. The Company will hold a conference call, conducted by Ajei Gopal, President and CEO, and Maria T. Shields, CFO, at 8:30 a.m. ET on May 03rd, 2018 to discuss its results and future outlook. Aspiring Member, please take a moment to register below for your free research report on ANSS at:

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

WSE has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit


For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +21-32-044-483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

View original content:—-2u-allscripts-healthcare-solutions-alteryx-and-ansys-300634294.html

SOURCE Wall St. Equities

Related Links

Category: Precious Metals